Alliance Imaging Names Richard J. Hall President of Alliance Oncology
Alliance Imaging, Inc. (NYSE:AIQ), a leading national provider of outpatient diagnostic imaging and radiation therapy services, has named Richard J. Hall President of Alliance Oncology and Mark Carol, M.D., as Chief Medical Officer for Alliance. Both executives will join Alliance on November 3, 2008 and will report to Paul Viviano, Chairman of the Board and Chief Executive Officer.
“These appointments fill key positions that will support our business performance and strategic growth initiatives,” said Viviano. “Rick and Mark are proven leaders who bring strong managerial skills as well as in-depth and industry-recognized expertise in health care. Their track record of success reinforces our vision of being the recognized leader in advanced medical imaging and radiation oncology, setting the standard for quality patient care, customer service and team member satisfaction.”
Mr. Hall’s extensive health care background includes more than 25 years experience in both the public and private sectors, including approximately four years as Senior Vice President of Business Development and Marketing for US Oncology, the nation’s largest oncology services provider. US Oncology is affiliated with more than 1,200 physicians practicing in approximately 472 locations, including 91 cancer centers and radiation facilities in 39 states. Mr. Hall began his career with American Hospital Supply and has also held senior leadership positions with General Medical Corporation, McKesson Corporation, PatientKeeper and BrightStar Healthcare.
Mr. Hall earned a bachelor’s degree in health care administration from Pennsylvania State University, and completed studies in the executive health care program at Duke University.
Dr. Carol is an industry veteran with more than 20 years experience in radiation oncology. Although he is a neurosurgeon by training, he followed his passion for research and innovation early in his career by founding and serving as President and Chief Technology Officer and eventually Chief Executive Officer of his own medical device company that developed and sold novel technology for use in neurosurgery and radiation therapy. In 1993, this company became known as NOMOS Corporation, where Dr. Carol pioneered the development and clinical application of intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT). Most recently, Dr. Carol served in an executive leadership position within Xoft.
Dr. Carol has published in the fields of radiation therapy and neurosurgery, holds patents in radiation therapy, neurosurgery and cardiology, and has been elected to honorary membership in the American Association of Physicists in Medicine. He recently was the inaugural recipient of the Ira Sohn Conference Foundation Prize in Pediatric Oncology, part of the Gotham prize, for his innovative ideas in the field of radiation therapy.
Dr. Carol earned a bachelor’s degree as an Independent Scholar from Amherst College, an M.D. with distinction in research from the University of Rochester, and served his residency in neurosurgery and a fellowship in trauma at the University of Maryland.
About Alliance Imaging
Alliance Imaging is a leading national provider of shared-service and fixed-site diagnostic imaging services, based upon annual revenue and number of diagnostic imaging systems deployed. Alliance provides imaging and therapeutic services primarily to hospitals and other healthcare providers on a shared and full-time service basis, in addition to operating a growing number of fixed-site imaging centers. The Company had 492 diagnostic imaging and radiation therapy systems, including 306 MRI systems and 83 PET or PET/CT systems, and served over 1,000 clients in 46 states at June 30, 2008. The Company operated 89 fixed-site imaging centers (five in unconsolidated joint ventures), which includes systems installed in hospitals or other buildings on or near hospital campuses, medical groups’ offices, or medical buildings and retail sites. The Company also operated 18 radiation therapy centers and stereotactic radiosurgery facilities (two radiation therapy centers are in unconsolidated joint ventures) as of June 30, 2008.
This press release contains forward-looking statements relating to future, not past, events, including statements related to investment and acquisition activity, the integration of acquired businesses into our business and our full year 2008 guidance. In this context, forward-looking statements often address our expected future business and financial results and often contain words such as “expects,”"anticipates,”"intends,”"plans,”"believes,”"seeks” or “will.” Forward-looking statements by their nature address matters that are uncertain and subject to risks. Such uncertainties and risks include: changes in the preliminary financial results and estimates due to the restatement or review of the Company’s financial statements; the nature, timing and amount of any restatement or other adjustments; the Company’s ability to make timely filings of its required periodic reports under the Securities Exchange Act of 1934; issues relating to the Company’s ability to maintain effective internal control over financial reporting and disclosure controls and procedures; difficulties the Company may face in connection with recent, pending or future acquisitions, including unexpected costs or liabilities resulting from the acquisitions, diversion of management’s attention from the operation of the Company’s business, and risks associated with integration of the acquisitions; and other risks and uncertainties identified in the Risk Factors section of the Company’s Form 10-K for the year ended December 31, 2007, in each case filed with the Securities and Exchange Commission. These uncertainties may cause actual future results or outcomes to differ materially from those expressed in the Company’s forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company does not undertake to update its forward-looking statements except as required under the federal securities laws.